Stem Cell Donor Reflects on His Opportunity to ‘Be the Match’

When Kevin Hoyle found out he was a match for a blood cancer patient in need of a stem cell transplant in 2015, he felt surprisingly uncomfortable — not from fear of the procedure, but because he didn’t feel he deserved the opportunity.   “I’m just an ordinary guy,” he thought. “Why should I have the honor of being able to offer someone a possibly life-altering scenario?”   … Read more

Pediatric Kidney Cancer Survivor Pays it Forward

Three-year-old Lia Scagnoli skipped across the “Bridge of Hope” connecting Boston Children’s Hospital and Dana-Farber Cancer Institute each time she had a chemotherapy infusion or other treatment for pediatric kidney cancer at Dana-Farber’s Jimmy Fund Clinic. Caregivers offering equal parts love, hope, and fun diversions gave her and her family a feeling of confidence that … Read more

PARP Inhibitor Drugs May Now be Standard Part of Follow-up Therapy for Some Ovarian Cancer Patients

On the strength of the results of a major international clinical trial, there is now a new standard of care for patients with an advanced form of ovarian cancer who have responded to initial chemotherapy. The trial, dubbed SOLO-1, found that these patients – newly diagnosed with ovarian cancer that carries a mutation in the … Read more